EXHIBIT 99.1

         

                   healthcare solutions for a new generation^SM

3420 Fairlane Farms Road, Suite C ¨  Wellington, Florida  33414  ¨   561.798.9800 (office)  ¨   561.296.3456 (fax)

The Quantum Group Announces Results of Annual Shareholder Meeting

WELLINGTON, Fla. (August 6, 2008) – The Quantum Group, Inc. (AMEX: QGP) (www.QuantumMD.com) has announced the results of the Annual Shareholder Meeting held on Friday, August 1, 2008.  At the meeting, shareholders of the Company re-elected Noel J. Guillama, Donald B. Cohen, Susan Darby Guillama, Jose de la Torre, Alberto G. Del Valle, Lawrence B. Fisher and Gregg M. Steinberg to the Board of Directors of the Company to serve until the next Annual Shareholder Meeting or until their successor is duly elected and qualified. In addition, the shareholders ratified Daszkal Bolton LLP’s appointment as independent auditors for the fiscal year ending October 31, 2008.  Finally, the shareholders also approved the 2007 Equity Incentive Plan.

Noel J. Guillama, President & CEO of The Quantum Group commented, “We are very pleased that all proposals presented before the shareholders were approved and by the opportunity to present our recently deployed PWeR™ system following the conclusion of the Annual Meeting.”  

About The Quantum Group, Inc.

The Quantum Group provides business process solutions, service chain management, strategic consulting and leading edge technology innovations to the healthcare industry.

Through our dynamic patient-centric architecture, we empower the communication that is critical for the coordination of care and take aim at the $600 billion inefficiency gap in the United States healthcare industry. We are guided by a mission to develop efficiencies, improve the quality of patient care and achieve cost reductions for the nation’s largest and fastest growing industry.  

We have developed leading-edge technology with the creation and deployment of a series of innovative patent-pending initiatives.  Through approximately 2,000 healthcare providers and multiple insurance company relationships under management, we are positioned to be a catalyst for change to the Florida healthcare industry.

Certain statements contained in this news release, which are not based on historical facts, are forward-looking statements as the term is defined in the Private Securities Litigation Reform Act of 1995, and are subject to substantial uncertainties and risks in part detailed in the respective company’s Securities and Exchange Commission 10-KSB, 10-QSB, S-8 and 8-K filings (and amendments thereto) that may cause actual results to materially differ from projections. Forward-looking statements can be identified by the use of words such as “expects,” “plans,” “will,” “may,” “anticipates,” “believes,” “should,” “intends,” “estimates” and other words of similar meaning.  These statements are subject to risks and uncertainties that cannot be predicted or quantified and, consequently, actual results may differ materially from those expressed or implied by these forward-looking statements.  Such risk factors include, without limitation, the ability of the Company to properly execute its business model, to raise substantial and immediate additional capital to implement its business model, to attract and retain executive, management and operational personnel, to execute additional contracts with payers, to expand the CHS network, to negotiate favorable current debt and future capital raises, to negotiate favorable agreements with a diversified provider base and to continue to supply the services needed by its HMO clients as well as physician clients.  The Company does not undertake any obligation to publicly update any forward-looking statements.  There can be no assurance that the provisional patents discussed in this press release will be granted by the US Patent and Trademark Office, or, if they are granted, they will not be challenged by third parties, or if not that we will be able to effectively use or commercialize such patents and/or we may not have the resources to deploy such technology. As a result, investors should not place undue reliance on these forward-looking statements.

FOR MORE INFORMATION, PLEASE CONTACT:

PR Financial Marketing

Jim Blackman: 713-256-0369

jim@prfmonline.com

Or

Danielle Amodio

Vice President Corporate Communications

The Quantum Group, Inc.

561.798.9800